Avanti POLAR LIPIDS, INC. Logo (WIPO, 03/26/2020)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark Avanti POLAR LIPIDS, INC. was filed as Figurative mark on 03/26/2020 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Armillary spheres, planetaria, astronomic orbits, atomic models, molecular models #Quadrilaterals #Letters presenting a special form of writing #Quadrilaterals containing one or more circles, ellipses or polygons (specify the content) #Series of letters in different dimensions
| Trademark form | Figurative mark |
| File reference | 1619461 |
| Countries | 
|
| Base trademark |
No. 88632780,
September 26, 2019
|
| Application date | March 26, 2020 |
| Expiration date | March 26, 2030 |
Trademark owner
700 Industrial Park Drive
Alabaster AL 35007
US
Alabaster AL 35007
US
Trademark representatives
Croda International Plc,
Cowick Hall,
GB
goods and services
01
Compounds for scientific or research use; adjuvants for
scientific or research use; chemical reagents for the
delivery of lipids for scientific or research use; standards
for use with analytical techniques, namely, mass
spectrometry (Terms too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Regulations);
compounds for scientific or research use, namely, lipids,
synthetic lipids, polymer modified lipids, lipids with
modified head groups, lipids with modified acyl chains,
bioactive lipids, fluorescent lipids, isotope labeled
lipids, oxidized lipids, sphingolipids, lipid extracts from
natural sources, biological compounds conjugated with
modified gold particles; compounds for scientific or
research use, namely, fatty acids, glycerolipids,
glycerophospholipids, sphingolipids, saccharolipids, sterol
lipids, prenol lipids, lipid preparations suitable for
protein crystallization, lipid preparations suitable for
protein solubilization, detergents, amphiphilic detergents,
and antibodies; diagnostic and analytical reagents for
scientific or research use; formulations comprising lipids
for scientific or research use; enzymes for scientific or
research use
05
Compounds for pharmaceutical or medical use; lipids, active
agents, additives, and excipients in pharmaceutical
preparations; adjuvants for pharmaceutical or medical use;
immunostimulatory compounds for pharmaceutical or medical
use; diagnostic probes and reagents for medical purposes;
test strips for the detection of bacterial infections for
medical use; isotopes for medical use
40
Manufacturing services for others in the field of active
agents, additives, or excipients in pharmaceutical
preparations; manufacturing services for others in the field
of lipids
42
Analytical services (terms too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Regulations);
scientific research for medical purposes; analytical
services in the field of lipids, nutraceuticals, food
products, pharmaceutical products, drug development and
commercialization; research and development and consultation
related thereto in the field of pharmaceuticals and
chemicals; research services for others (terms too vague in
the opinion of the International Bureau – Rule 13 (2) (b) of
the Regulations); research services for others in the field
of lipids, nutraceuticals, food products, pharmaceutical
products, drug development; research services for others in
the field of drug commercialization (terms too vague in the
opinion of the International Bureau – Rule 13 (2) (b) of the
Regulations); lipidomics services; cGMP testing services;
formulation services in the field of pharmaceuticals,
lipids, and chemicals; cGMP manufacture of active agents,
additives, or excipients; cGMP manufacture of lipids;
providing information relating to lipids and related
compounds for scientific and medical research purposes
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 13, 2023 | 2023/11 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 3, 2023 | 2023/6 Gaz | KR | RAW: No Effect Limitation |
| January 31, 2023 | 2023/5 Gaz | CA | Rejection |
| January 5, 2023 | 2023/1 Gaz | NZ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 24, 2022 | 2022/48 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 16, 2022 | 2022/46 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 15, 2022 | 2023/2 Gaz | RAW: Limitation | |
| October 24, 2022 | 2022/43 Gaz | KR | Rejection |
| October 3, 2022 | 2022/42 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 2, 2022 | 2022/36 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 31, 2022 | 2022/35 Gaz | MX | Rejection |
| July 28, 2022 | 2022/30 Gaz | JP | Rejection |
| March 9, 2022 | 2022/10 Gaz | EM | Rejection |
| February 9, 2022 | 2022/9 Gaz | IL | Rejection |
| February 7, 2022 | 2022/9 Gaz | CN | Rejection |
| January 31, 2022 | 2022/5 Gaz | RU | Rejection |
| January 21, 2022 | 2022/4 Gaz | SG | Rejection |
| January 6, 2022 | 2022/2 Gaz | AU | Rejection |
| December 22, 2021 | 2021/52 Gaz | NZ | Rejection |
| March 26, 2020 | 2021/39 Gaz | US | Registration |
ID: 141619461